Kontaktinformationen, Karte und Wegbeschreibungen, Kontaktformulare, Öffnungszeiten, Dienstleistungen, Bewertungen, Fotos, Videos und Ankündigungen von TRB Chemedica International, Route des Jeunes 33bis, Eaux-Vives.
For over 40 years, TRB Chemedica International have been successfully developing, producing, and promoting APIs, pharmaceutical products, and medical devices in three specialized areas: ophthalmology, rheumatology, and neurology. TRB Chemedica is a Swiss pharmaceutical company, focus on research & development in specific therapeutic areas, including rheumatology, ophthalmology and neurology.
26/02/2026
VISMED® unveils a fresh new look.
Trusted for 25 years, VISMED® is unveiling a modern and refreshed packaging design. Discover the details behind this next chapter. https://pulse.ly/zztqfnoaww
23/02/2026
Replay available 🎥 | Advancing Small Joints Osteoarthritis Care (TMJ focus). If you missed our recent session, you can now watch the replay and hear leading experts discuss practical approaches to temporo-mandibular joint (TMJ) osteoarthritis.
Watch the replay here: https://pulse.ly/qu62dzau8n
08/02/2026
Join us on Monday, March 23rd, from 6:00 PM to 7:00 PM (CET) for an expert-led TRB Academy session with Dr. Henning Ott. https://bit.ly/4tfzvs9
📌Topic: Balancing Benefits and Risks: A Critical Evaluation of Steroid and Hyaluronic-Acid Injections for Tendinopathy. Explore the key differences between steroid and hyaluronic-acid injections and how to weigh efficacy, safety, and practical considerations to support patient care and prevent long-terms complications.
19/01/2026
Early registration for the TRB Ocular Surface Academy 2026 is now open! Join this live-streamed event to connect with leading experts and explore the latest advancements in ocular surface health. Secure your free spot today https://bit.ly/49IaxJ7
18/12/2025
18/11/2025
The replay of our TRB Academy webinar held on June 30th, “Tailoring Injectable Treatments for Tendinopathies: From Evidence to Clinical Practice,” is now available. 👉Watch the replay https://bit.ly/4pdfxeG
Presented by Prof. Anja Hirschmüller, the session offer clear, evidence-based guidance on injectable treatements for tendinopathy management. If you missed the live session, you can now watch the full presentation and Q&A.
07/11/2025
Join us on Monday, December 1, from 6:00 PM to 7:00 PM (CET) for an expert-led TRB Academy session with Prof. Alkis Kalliakmanis.
Register now: https://bit.ly/3XhPHuc
📌 Topic: Optimizing Recovery After Arthroscopy: Tailored Pathways to Sport and Work Reintegration
Explore evidence-based strategies and personalized approaches to optimize post-arthroscopy recovery and support a safe, efficient return to sport and work.
Don’t miss this opportunity to learn more about rehabilitation approaches.
10/10/2025
This coming , how can we truly empower mobility, ease pain, and restore quality of life for millions worldwide?
At TRB Chemedica we believe the answer lies in progress, built on empathy and science — because everyone deserves the freedom to move without limits.
To everyone affected: You are not alone. Progress is possible. Together, we move forward. Learn more about our dedicated efforts in the field of arthritis treatment. https://bit.ly/4oeA3LQ
29/09/2025
Save the date 📅 to connect with us at our booth to discuss our musculoskeletal and dry eye therapies, as well as opportunities in in-licensing, out-licensing, and global distribution.
👉 Learn more about our expertise and CPHI Europe 2025 https://bit.ly/3Vk4mEc
11/09/2025
We’re proud to exhibit at ISIAT 2025, where global experts in intra-articular therapy will explore the latest in viscosupplementation, orthobiologics, and more. From consensus updates to joint preservation in athletes and ultrasound-guided injection workshops, this edition brings valuable insights for specialists in joint and musculoskeletal health.
💬 Meet the at Booth E in Bucharest and discover how our Swiss-engineered solutions are advancing joint care and mobility.
Osteoarthritis in small joints and TMJ can be a real challenge in clinical practice. Here’s a chance to deepen your expertise in just 45 minutes with a leading voice in the field.
📅 Date: Monday, September 29th
⏰ Time: 7:15 – 8:00 PM (CEST)
Join us for a focused clinical webinar on small joint and temporomandibular joint (TMJ) management, led by Stefano Stea, a consultant oral and maxillofacial surgeon in the UK. Register here https://one.wisembly.com/trbacademy
25/08/2025
Mark your calendars and join us at ESCRS 2025 in Copenhagen, from 12–16 September!
We will be exhibiting at Booth C4.018 and are excited to present our latest solutions in ocular surface health.
This year’s congress features exciting extras like the BoSS sustainability track and the 5K Charity Run through Amager Fælled, making it a must-attend event for ophthalmologists committed to innovation and impact. We look forward to connecting with you in Copenhagen!
Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von TRB Chemedica International erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.
We are a market-leading pharma and biotechnology company, based in Switzerland and operating around the world.
Founded by Dr Guido Di Napoli in 1980, TRB Chemedica followed a gradual business evolution and expansion through the development of a worldwide network of subsidiaries and distributors.
For over 30 years, we have been successfully developing, producing, and promoting APIs, pharmaceutical products, and medical devices in three specialized areas: ophthalmology, rheumatology, and neurology.
Our medium-sized company, supported by an exclusive network of affiliates, agents and partners, makes us efficient and responsive in the market, with the ability to develop customized solutions for patients and partners in our three focus areas that are hyluronic acid diacerein and GM1 ganglioside.
As a family firm from our foundation, we have strong values that are shared by everyone from the boardroom to the factory.